Another cure from cancer. Again! (Post No 6)

And this time the magic cure was developed by BMS and against lung cancer! Just take a look:

“This could be a breakthrough for lung cancer,” said Julie Brahmer, an oncologist at the Johns Hopkins Kimmel Cancer Center in Baltimore.

In an initial trial of 240 patients, the Bristol-Myers drug, known as BMS-936558, shrunk tumors in 24 of 95 melanoma patients, 10 of 33 people with kidney cancer and 13 of 75 of those with advanced lung cancer, according to preliminary information on the data, gathered in the first phase of tests usually needed for regulatory approval.

If the result holds up in further trials, the therapy may become a “backbone” for future combination treatments that attack cancer by weakening it with chemotherapy while simultaneously unleashing an immune system assault, said Seamus Fernandez, an analyst at Leerink Swann & Co. in Boston. In this case, Bristol-Myers’s drug may reap more than $4 billion a year in sales, he said.

$4 billion A YEAR! Unbelievable! I wish a success to BMS, however something deep inside me is saying that this is the next hype and PR campaign. Do you know why? BMS-936558 is the known mAb product Ipilimumab developed against melanoma. And as other mAbs it doubtfully can produce any magic outcome therefore I am just waiting for the coming disappointed results from the clinical trials. See examples of the failure here and here. Sorry for that.